Of Humans and Hamsters: The Hamster Buccal Pouch Carcinogenesis Model as a Paradigm for Oral Oncogenesis and Chemoprevention
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
843-852
Author(s):
S. Nagini
Recent Advances in Validating MDM2 as a Cancer Target
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
882-903
Author(s):
Elizabeth R. Rayburn, Scharri J. Ezell and Ruiwen Zhang
Novel Anti-Prostate Cancer Curcumin Analogues That Enhance Androgen Receptor Degradation Activity
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
904-912
Author(s):
Q. Shi, C. C.-Y. Shih and K. H. Lee
Targeting Epidermal Growth Factor Receptor in Solid Tumors: Critical Evaluation of the Biological Importance of Therapeutic Monoclonal Antibodies
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
3797-3804
Author(s):
Ch. Gialeli, D. Kletsas, D. Mavroudis, H. P. Kalofonos, G. N. Tzanakakis and N. K. Karamanos
Selective Matrix Metalloproteinase Inhibitors for Cancer
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
3805-3827
Author(s):
Nian-Guang Li, Zhi-Hao Shi, Yu-Ping Tang and Jin-Ao Duan
Role of Nuclear Steroid Receptors in Apoptosis
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
3886-3902
Author(s):
Joana D. Amaral, Susana Sola, Clifford J. Steer and Cecília M.P. Rodrigues
Editorial [Hot topic: Phosphodiesterase-5 Inhibitors and their Use in the Treatment of Urological Conditions (Executive Editor: Perimenis Petros)]
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
3463-3463
Author(s):
Perimenis Petros
Phosphodiesterase Type 5 Inhibitors: Unmet Needs
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
3476-3485
Author(s):
K. Hatzimouratidis and D. G. Hatzichristou
Prophylaxis of Erectile Function After Radical Prostatectomy with Phosphodiesterase Type 5 Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
3496-3501
Author(s):
F. Deho, A. Gallina, A. Salonia, A. Briganti, N. Suardi, G. Zanni, G. Guazzoni, P. Rigatti and F. Montorsi
Fibroblast Growth Factor-2 Antagonist and Antiangiogenic Activity of Long-Pentraxin 3-Derived Synthetic Peptides
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
3577-3589
Author(s):
D. Leali, P. Alessi, D. Coltrini, M. Rusnati, L. Zetta and M. Presta